{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:19:49Z","timestamp":1787239189134,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T00:00:00Z","timestamp":1645833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T00:00:00Z","timestamp":1645833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Renal cell carcinoma (RCC) is a lethal urinary malignancy. Circular RNAs (circRNAs) contribute to the malignant phenotype and progression of several types of human cancers, including RCC. In this study, we identified relatively low hsa_circ_0060927 (circCYP24A1) expression in RCC tissue through high-throughput sequencing and RT\u2013qPCR. Fluorescence in situ hybridization (FISH) was used to validate the expression and subcellular localization of circCYP24A1 in RCC tissues. CCK-8, Transwell, EdU, and wound-healing assays indicated that circCYP24A1 overexpression inhibited the proliferation, invasion, and migration of RCC cells. Dual-luciferase reporter, RNA immunoprecipitation (RIP), FISH, and RNA-pulldown assays verified that circCYP24A1 inhibited RCC progression by sponging miR-421, thus inducing CMTM-4 expression. Xenograft assays and metastasis models further indicated that circCYP24A1 significantly inhibited the metastasis and proliferation of RCC cells in vivo. Taken together, circCYP24A1 is a prognosis-related circRNA in RCC that functions through the circCYP24A1\/miR-421\/CMTM-4 axis to modulate RCC progression.<\/jats:p>","DOI":"10.1038\/s41419-022-04623-0","type":"journal-article","created":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T03:02:36Z","timestamp":1645844556000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["CircCYP24A1 hampered malignant phenotype of renal cancer carcinoma through modulating CMTM-4 expression via sponging miR-421"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4574-2529","authenticated-orcid":false,"given":"Xiaorong","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaolin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6011-4067","authenticated-orcid":false,"given":"Chen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9706-0880","authenticated-orcid":false,"given":"Yonghui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0124-9433","authenticated-orcid":false,"given":"Wei","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,26]]},"reference":[{"key":"4623_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA:. Cancer J Clin. 2020;70:7\u201330.","journal-title":"Cancer J Clin"},{"key":"4623_CR2","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.eururo.2021.01.043","volume":"79","author":"N Singla","year":"2021","unstructured":"Singla N. Rational Therapeutic Sequencing in Metastatic Renal Cell Carcinoma: Insights Gained from IMmotion150. Eur Urol. 2021;79:674\u20135.","journal-title":"Eur Urol"},{"key":"4623_CR3","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1016\/j.ymthe.2021.05.020","volume":"9","author":"G Hu","year":"2021","unstructured":"Hu G, Ma J, Zhang J, Chen Y, Liu H, Huang Y, et al. Hypoxia-induced lncHILAR promotes renal cancer cell invasion and metastasis via ceRNA for the miR-613\/206\/1-1-3p\/Jagged-1\/Notch\/CXCR4 signaling pathway. Mol Ther. 2021;9:2979\u201394.","journal-title":"Mol Ther"},{"key":"4623_CR4","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1002\/hep.30671","volume":"70","author":"Q Li","year":"2019","unstructured":"Li Q, Pan X, Zhu D, Deng Z. Circular RNA MAT2B promotes glycolysis and malignancy of hepatocellular carcinoma via the miR8\/PKM2 axis under hypoxic stress. Hepatology. 2019;70:1298\u201316.","journal-title":"Hepatology"},{"key":"4623_CR5","doi-asserted-by":"publisher","first-page":"22.","DOI":"10.1186\/s12943-020-1147-3","volume":"19","author":"P Wu","year":"2020","unstructured":"Wu P, Mo Y, Peng M, Tang T, Xiong W. Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA. Mol Cancer. 2020;19:22.","journal-title":"Mol Cancer"},{"key":"4623_CR6","doi-asserted-by":"publisher","first-page":"9712","DOI":"10.1111\/jcmm.15529","volume":"24","author":"J Zeng","year":"2020","unstructured":"Zeng J, Feng Q, Wang Y, Xie G, Li Y, Yang Y, et al. Circular RNA circ_001842 plays an oncogenic role in renal cell carcinoma by disrupting microRNA-502-5p-mediated inhibition of SLC39A14. J Cell Mol Med 2020;24:9712\u201325.","journal-title":"J Cell Mol Med"},{"key":"4623_CR7","doi-asserted-by":"publisher","first-page":"10646","DOI":"10.1002\/jcp.27744","volume":"234","author":"Y Xiong","year":"2019","unstructured":"Xiong Y, Zhang J, Song C. CircRNA ZNF609 functions as a competitive endogenous RNA to regulate FOXP4 expression by sponging miR-138-5p in renal carcinoma. J Cell Physiol. 2019;234:10646\u201354.","journal-title":"J Cell Physiol"},{"key":"4623_CR8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.canlet.2019.10.017","volume":"469","author":"Q Chen","year":"2020","unstructured":"Chen Q, Liu T, Bao Y, Zhao T, Wang J, Wang H, et al. CircRNA cRAPGEF5 inhibits the growth and metastasis of renal cell carcinoma via the miR-27a-3p\/TXNIP pathway. Cancer Lett. 2020;469:68\u201377.","journal-title":"Cancer Lett"},{"key":"4623_CR9","doi-asserted-by":"crossref","unstructured":"Li J, Huang C, Zou Y, Ye J, Yu J, Gui Y. CircTLK1 promotes the proliferation and metastasis of renal cell carcinoma by sponging miR-136-5p. Mol Cancer. 2020;19:103.","DOI":"10.1186\/s12943-020-01225-2"},{"key":"4623_CR10","doi-asserted-by":"publisher","first-page":"9001","DOI":"10.1007\/s13277-015-4578-5","volume":"37","author":"S Zhou","year":"2016","unstructured":"Zhou S, Wang B, Hu J, Zhou Y, Jiang M, et al. miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma. Tumor Biol. 2016;37:9001\u20137.","journal-title":"Tumor Biol"},{"key":"4623_CR11","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.2147\/CMAR.S167432","volume":"10","author":"Y Li","year":"2018","unstructured":"Li Y, Cui X, Li Y, Zhang T, Li S. Upregulated expression of miR-421 is associated with poor prognosis in non-small-cell lung cancer. Cancer Manag Res. 2018;10:2627\u201333.","journal-title":"Cancer Manag Res"},{"key":"4623_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.canlet.2020.06.009","volume":"490","author":"M Li","year":"2020","unstructured":"Li M, Guo H, Wang Q, Chen K, Yang Y. Pancreatic stellate cells derived exosomal miR-5703 promotes pancreatic cancer by downregulating CMTM4 and activating PI3K\/Akt pathway. Cancer Lett. 2020;490:20\u201330.","journal-title":"Cancer Lett"},{"key":"4623_CR13","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1093\/abbs\/gmz084","volume":"51","author":"H Xue","year":"2019","unstructured":"Xue H, Li T, Wang P, Mo X, Han W. CMTM4 inhibits cell proliferation and migration via AKT, ERK1\/2, and STAT3 pathway in colorectal cancer. Acta Bioch Bioph Sin. 2019;51:915\u201324.","journal-title":"Acta Bioch Bioph Sin"},{"key":"4623_CR14","doi-asserted-by":"publisher","first-page":"133.","DOI":"10.1186\/s12943-019-1060-9","volume":"18","author":"J Bi","year":"2019","unstructured":"Bi J, Liu H, Dong W, Xie W, Lin T. Circular RNA circ-ZKSCAN1 inhibits bladder cancer progression through miR-1178-3p\/p21 axis and acts as a prognostic factor of recurrence. Mol Cancer. 2019;18:133.","journal-title":"Mol Cancer"},{"key":"4623_CR15","doi-asserted-by":"publisher","first-page":"151.","DOI":"10.1186\/s12943-019-1072-5","volume":"18","author":"D Xue","year":"2019","unstructured":"Xue D, Wang H, Chen Y, Shen D, Xia L. Circ-AKT3 inhibits clear cell renal cell carcinoma metastasis via altering miR-296-3p\/E-cadherin signals. Mol Cancer. 2019;18:151.","journal-title":"Mol Cancer"},{"key":"4623_CR16","doi-asserted-by":"publisher","first-page":"30.","DOI":"10.1186\/s12943-020-1135-7","volume":"19","author":"M Lei","year":"2020","unstructured":"Lei M, Zheng G, Ning Q, Zheng J, Dong D. Translation and functional roles of circular RNAs in human cancer. Mol Cancer. 2020;19:30.","journal-title":"Mol Cancer"},{"key":"4623_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2183-z","volume":"10","author":"H Hong","year":"2019","unstructured":"Hong H, Zhu H, Zhao S, Wang K, Li H. The novel circCLK3\/miR-320a\/FoxM1 axis promotes cervical cancer progression. Cell Death Dis. 2019;10:950.","journal-title":"Cell Death Dis"},{"key":"4623_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20527-z","volume":"12","author":"B Li","year":"2021","unstructured":"Li B, Zhu L, Lu C, Wang C, Qin W. circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity. Nat Commun. 2021;12:295.","journal-title":"Nat Commun"},{"key":"4623_CR19","doi-asserted-by":"publisher","first-page":"112.","DOI":"10.1186\/s12943-020-01208-3","volume":"19","author":"M Xie","year":"2020","unstructured":"Xie M, Yu T, Jing X, Ma L, Xu T. Exosomal circSHKBP1 promotes gastric cancer progression via regulating the miR-582-3p\/HUR\/VEGF axis and suppressing HSP90 degradation. Mol Cancer. 2020;19:112.","journal-title":"Mol Cancer"},{"key":"4623_CR20","doi-asserted-by":"publisher","first-page":"298.","DOI":"10.1038\/s41392-020-00375-5","volume":"5","author":"J Xu","year":"2020","unstructured":"Xu J, Ji L, Liang Y, Wan Z, Cai X. CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1. Signal Transduct Target Ther. 2020;5:298.","journal-title":"Signal Transduct Target Ther"},{"key":"4623_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/cas.13857","volume":"110","author":"C Yang","year":"2019","unstructured":"Yang C, Wu S, Wu X, Zhou X, Jin S. Silencing circular RNA UVRAG inhibits bladder cancer growth and metastasis by targeting the microRNA-223\/fibroblast growth factor receptor 2 axis. Cancer Sci. 2019;110:99\u2013106.","journal-title":"Cancer Sci"},{"key":"4623_CR22","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.3389\/fonc.2020.01685","volume":"10","author":"C Yang","year":"2020","unstructured":"Yang C, Zhang Z, Ye F, Mou Z, Jiang H. FGF18 inhibits clear cell renal cell carcinoma proliferation and invasion via regulating epithelial-mesenchymal transition. Front Oncol. 2020;10:1685.","journal-title":"Front Oncol"},{"key":"4623_CR23","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.omtn.2021.01.009","volume":"23","author":"C Yang","year":"2021","unstructured":"Yang C, Mou Z, Zhang Z, Wu S, Jiang H. Circular RNA RBPMS inhibits bladder cancer progression via miR-330-3p\/RAI2 regulation. Mol Ther Nucleic Acids. 2021;23:872\u201386.","journal-title":"Mol Ther Nucleic Acids"},{"key":"4623_CR24","doi-asserted-by":"publisher","first-page":"719.","DOI":"10.1038\/s41419-021-03977-1","volume":"12","author":"C Yang","year":"2021","unstructured":"Yang C, Mou Z, Wu S. High-throughput sequencing identified circular RNA circUBE2K mediating RhoA associated bladder cancer phenotype via regulation of miR-516b-5p\/ARHGAP5 axis. Cell Death Dis. 2021;12:719.","journal-title":"Cell Death Dis"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04623-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04623-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04623-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T09:45:58Z","timestamp":1669283158000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04623-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,26]]},"references-count":24,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["4623"],"URL":"https:\/\/doi.org\/10.1038\/s41419-022-04623-0","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,26]]},"assertion":[{"value":"9 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"For patients\u2019 tissue and blood, a written informed consent was acquired from each participant or his\/her relatives, and the project was approved by the Committee of Huashan Hospital, Fudan University, Shanghai, China, reference number KY2011-009. The animal experiments were approved by the Board and Ethics Committee of Huashan Hospital, Fudan University, Shanghai, China, reference number 2021JS Huashan Hospital-173.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"190"}}